CBITS-RTM Pilot Study
2. juli 2026 oppdatert av: University of California, San Francisco
Preventing Substance Use Among Incarcerated Youth Through Addressing Posttraumatic Stress
This pilot study, conducted in partnership with juvenile detention centers, evaluates an adapted CBITS-RTM intervention delivered in a detention school setting.
Studieoversikt
Status
Har ikke rekruttert ennå
Detaljert beskrivelse
The study examines the intervention's feasibility and acceptability, as well as its effectiveness in reducing incarcerated youth's posttraumatic stress symptoms, improving academic functioning, and decreasing intentions to use substances post-release.
Studietype
Intervensjonell
Registrering (Antatt)
28
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Johanna B Folk, PhD
- Telefonnummer: 415-602-9521
- E-post: johanna.folk@ucsf.edu
Studer Kontakt Backup
- Navn: Jeanne McPhee, PhD
- E-post: jeanne.mcphee@ucsf.edu
Studiesteder
-
-
California
-
San Francisco, California, Forente stater, 94131
- UCSF Zuckerberg San Francisco General Hospital
-
Ta kontakt med:
- Principal Investigator, PhD
- E-post: johanna.folk@ucsf.edu
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Youth must 1) be currently incarcerated in a partnering juvenile detention center, 2) be between 13-18 years of age, and 3) have a minimum of 3 months remaining on their sentence (i.e., sufficient time required to complete CBITS-RTM). Youth will complete a screening with a study team member involving the 2-item Abbreviated PTSD Checklist-Civilian version, with scores ≥4 considered a positive screen
- Clinicians are eligible if they are behavioral health staff working with youth at the detention school..
Exclusion Criteria:
- Observable cognitive or developmental delays or active psychosis that would interfere with completing consent, assessment or intervention.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Adapted CBITS-RTM Intervention
|
The Cognitive Behavioral Intervention for Trauma in Schools (CBITS) program is a school-based, group and individual intervention designed to reduce symptoms of post-traumatic stress disorder (PTSD), depression, and behavioral problems, and to improve functioning, grades and attendance, and coping skills.
The CBITS intervention was adapted to juvenile justice settings with an added Racial Trauma Module (RTM), which provides youth with an overview of the effects of racism on levels of traumatic stress.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Child PTSD Symptom Scale (CPSS)
Tidsramme: Baseline, 3 months post-baseline
|
The CPSS is used to measure posttraumatic stress among youth (8-18 years).
It assesses past month posttraumatic stress symptom severity and impairment of endorsed symptoms on daily functioning.
Scores range from 0-80, with 31+ indicating probable PTSD.
|
Baseline, 3 months post-baseline
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Youth Alcohol and Drug Use Survey
Tidsramme: Baseline, 3 months post-baseline
|
The Youth Alcohol and Drug Use Survey will be used to gather youth's intention to use substances post-release using items rated on a scale from 1 (unlikely) to 10 (very likely).
|
Baseline, 3 months post-baseline
|
|
Texas Christian University (TCU) Drug Screen
Tidsramme: Baseline, 3-months post-baseline
|
The TCU will be administered to gather information on substance use quantity and frequency as well as risk for SUD (corresponds with DSM-5 criteria) on the 3-months prior to incarceration and past 3 months at post-release.
|
Baseline, 3-months post-baseline
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Youth Background Characteristics
Tidsramme: Baseline
|
Demographics questionnaire used to gather standard demographics (e.g., age, gender, race) and information such as state agency involvement (e.g., age at first contact with juvenile legal system, number of prior arrests), immigration status.
|
Baseline
|
|
Treatment Acceptability Form
Tidsramme: 3-months post-baseline
|
This form will be used to assess the acceptability of the adapted CBITS-RTM intervention.
Items are scored from 1 "Strongly disagree" to 5 "Strongly agree."
Scores range from 10-50 with higher scores indicating higher acceptability.
|
3-months post-baseline
|
|
CBITS-RTM Group Evaluation Posttest
Tidsramme: 3-months post-baseline
|
This will assess knowledge of trauma, changes in ability to cope with stress, and acceptability of the intervention and its delivery.
Items are true/false or qualitative in nature.
|
3-months post-baseline
|
|
Clinician personal and professional background characteristics
Tidsramme: Baseline
|
Questionnaire used to gather personal and professional background characteristics (e.g., clinical discipline, experience with trauma treatment, years of practice in juvenile detention setting).
|
Baseline
|
|
Cognitive Behavioral Intervention for Trauma in Schools-Fidelity Adherence Measure 2.0
Tidsramme: 20% of the sessions
|
This measure will be used to assess how closely clinicians adhere to the adapted CBITS-RTM intervention.
The scale describes the core components expected to be covered in each session, and the rater indicates the degree to which each component was delivered with fidelity using a 4-point item rating ranging from 0 (not covered at all) to 3 (covered thoroughly).
Higher item scores indicate greater fidelity to the intervention curriculum.
|
20% of the sessions
|
|
The Evidence-Based Practice Attitude Scale (EBPAS)
Tidsramme: Baseline
|
The EBPAS (15-items) will be used to assess clinician's attitudes toward adopting new evidence-based practices (EBPs).
It consists of four subscales: appeal, requirements, openness, and divergence.
Items are rated on a 5-point Likert scale from 0 (not at all) to 4 (to a very great extent).
Higher scores on the Appeal, Requirements, and Openness subscales indicate more positive attitudes toward adopting EBPs, whereas higher Divergence scores indicate less favorable attitudes.
|
Baseline
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Etterforskere
- Hovedetterforsker: Johanna Folk, PhD, University of California, San Francisco
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
1. september 2026
Primær fullføring (Antatt)
30. juni 2027
Studiet fullført (Antatt)
31. desember 2027
Datoer for studieregistrering
Først innsendt
26. juni 2026
Først innsendt som oppfylte QC-kriteriene
26. juni 2026
Først lagt ut (Faktiske)
2. juli 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
6. juli 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
2. juli 2026
Sist bekreftet
1. juli 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 25-45799
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .